Last reviewed · How we verify
NCT06858540
Blended Unified Protocol in Chinese Adolescents With Non-Suicidal Self-Injury
NA trial testing Unified protocol for transdiagnostic treatment of emotional disorders in adolescents in Non-suicidal Self-injury (NSSI) in 12 participants. Currently enrolling.
30 October 2025
Quick facts
| Lead sponsor | Jian-Jun Ou |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 29 April 2025 |
| Primary completion | 30 October 2025 |
| Estimated completion | 30 October 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Unified protocol for transdiagnostic treatment of emotional disorders in adolescents
Conditions studied
- Non-suicidal Self-injury (NSSI) — all drugs for Non-suicidal Self-injury (NSSI) →
Sponsor
Jian-Jun Ou — full company profile →
Who can join
Adults 12 to 17, any sex, with Non-suicidal Self-injury (NSSI). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study utilizes the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) to address non-suicidal self-injury among Chinese adolescents. This program is an annualized cognitive-behavioral therapy designed for adolescents aged 12-17 years who engage in non-suicidal self-injury behavior. Its primary goal is to reduce the intensity and frequency of distressing emotional experiences by teaching adolescents how to confront and respond to these emotions in more adaptive ways. In turn, this helps reduce self-injury impulses and behaviors. The UP-A is adapted to the Chinese cultural context and delivered as a blended treatment, combining face-to-face and online sessions. The study will assess the feasibility, acceptability, and preliminary efficacy of this intervention through a single-arm design, which includes pretest, posttest, and follow-up assessments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06858540
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Jian-Jun Ou trials
Trials by the same sponsor.
- NCT07282366 — Video Intervention to Reduce Depression-related Stigma Among Adolescents · NA · not yet recruiting
- NCT07110181 — Blended Unified Protocol for Chinese Adolescents With Non-Suicidal Self-Injury: A Randomized Controlled Trial · NA · not yet recruiting
- NCT07047976 — Mechanism Study of Sulforaphane in ASD Improvement · NA · withdrawn
- NCT06305988 — Neuroregulatory Effect and Mechanism of tDCS on Medial Prefrontal Cortex in ASD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06858540 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jian-Jun Ou
- Last refreshed: 4 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06858540.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing